Skip to main content
Log in

Functioning of Proteasomes in Lymphogenic Metastasizing of Non-Small-Cell Lung Cancer

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Chymotrypsin- and caspase-like activities and expression of the total proteasome pool subunits (α1α2α3α5α6α7) were studied in patients with non-small-cell lung cancer. Proteasome activities were higher in the primary tumors and lymphogenic metastases than in corresponding adjacent lung tissue. The content of α1α2α3α5α6α7 subunits decreased in metastases and remained unchanged in primary tumor tissue. The development of metastatic process in non-small-cell lung cancer was associated with nonlinear changes in proteasome activities and content in primary tumor tissue and lymphogenic metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tsimokha AS. Proteasomes: their role in cellular processes. Tsitologiya. 2010;52(4):277-300. Russian.

    CAS  Google Scholar 

  2. Ben-Shahar S, Komlosh A, Nadav E, Shaked I, Ziv T, Admon A, DeMartino GN, Reiss Y. 26 S proteasome-mediated production of an authentic major histocompatibility class Irestricted epitope from an intact protein substrate. J. Biol. Chem. 1999;274(31):21,963-21,972.

    Article  CAS  Google Scholar 

  3. The Cancer Degradome: Proteases in Cancer Biology. Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF, eds. New York, 2008.

  4. Ivanova EV, Kondakova IV, Spirina LV, Afanas’ev SG, Avgustinovich AV, Cheremisina OV. Chymotrypsin-like activity of proteasomes and total calpain activity in gastric and colorectal cancer. Bull. Exp. Biol. Med. 2014;157(6):781-784.

    Article  PubMed  CAS  Google Scholar 

  5. Kondakova IV, Spirina LV, Shashova EE, Koval VD, Kolomiets LA, Chernyshova AL, Slonimskaya EM. Proteasome activity in tumors of the female reproductive system. Rus. J. Bioorgan. Chem. 2012;38(1):89-92.

    Article  CAS  Google Scholar 

  6. Liu F, Zhou J, Zhou P, Chen W, Guo F. The ubiquitin ligase CHIP inactivates NF-κB signaling and impairs the ability of migration and invasion in gastric cancer cells. Int. J. Oncol. 2015;46(5):2096-2106.

    Article  PubMed  CAS  Google Scholar 

  7. Ma W, Kantarjian H, Bekele B, Donahue AC, Zhang X, Zhang ZJ, O’Brien S, Estey E, Estrov Z, Cortes J, Keating M, Giles F, Albitar M. Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome. Clin. Cancer Res. 2009;15(11):3820-3826.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Mani A, Gelmann EP. The ubiquitin-proteasome pathway and its role in cancer. J. Clin. Oncol. 2005;23(21):4776-4789.

    Article  PubMed  CAS  Google Scholar 

  9. Shashova EE, Astakhova TM, Plekhanova AS, Bogomyagkova YV, Lyupina YV, Sumedi IR, Slonimskaya EM, Erokhov PA, Abramova EB, Rodoman GV, Kuznetsov NA, Kondakova I. V, Sharova NP, Choinzonov EL. Changes in proteasome chymotrypsin-like activity during the development of human mammary and thyroid carcinomas. Bull. Exp. Biol. Med. 2013;156(2):242-244.

    Article  PubMed  CAS  Google Scholar 

  10. Shashova EE, Lyupina YV, Glushchenko SA, Slonimskaya EM, Savenkova OV, Kulikov AM, Gornostaev NG, Kondakova IV, Sharova NP. Proteasome functioning in breast cancer: connection with clinical-pathological factors. PLoS One. 2014;9(10):e109933. doi: https://doi.org/10.1371/journal.pone.0109933.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Spirina LV, Kondakova IV, Koval’ VD, Kolomiets LA, Chernyshova AL, Choinzonov EL, Sharova NP. Proteasome activity and their subunit composition in endometrial cancer tissue: correlations with clinical morphological parameters. Bull. Exp. Biol. Med. 2012;153(4):501-504.

    Article  PubMed  CAS  Google Scholar 

  12. Xie Y. Structure, assembly and homeostatic regulation of the 26S proteasome. J. Mol. Cell Biol. 2010;2(6):308-317.

    Article  PubMed  CAS  Google Scholar 

  13. Yerlikaya A, Yöntem M. The significance of ubiquitin proteasome pathway in cancer development. Recent Pat. Anticancer Drug Discov. 2013;8(3):298-309.

    Article  PubMed  CAS  Google Scholar 

  14. Yoo Y, Ho HJ, Wang C, Guan JL. Tyrosine phosphorylation of cofilin at Y68 by v-Src leads to its degradation through ubiquitin-proteasome pathway. Oncogene. 2010;29(2):263-272.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. S. Kolegova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 165, No. 4, pp. 481-484, April, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kolegova, E.S., Kondakova, I.V., Zav’yalov, A.A. et al. Functioning of Proteasomes in Lymphogenic Metastasizing of Non-Small-Cell Lung Cancer. Bull Exp Biol Med 165, 486–489 (2018). https://doi.org/10.1007/s10517-018-4200-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4200-0

Key Words

Navigation